Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery

Obstetrics and Gynecology

Volumn 93, Issue 4 SUPPL., 1999, Pages 517-522

  Crane, Joan M G ^a   Armson, B Anthony ^b   Dodds, Linda ^b   Feinberg, Ronald F ^b   Kennedy, William ^b   Kirkland, Susan A ^b  

^a Grace General Hospital   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ADOLESCENT; ADULT; ARTICLE; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; PARITY; PREDICTION; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; STATISTICAL ANALYSIS; VAGINA SMEAR; VAGINITIS;

ADULT; CERVIX UTERI; FEMALE; FIBRONECTINS; HUMANS; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; REGRESSION ANALYSIS; RISK; SENSITIVITY AND SPECIFICITY; VAGINA; VAGINOSIS, BACTERIAL;

EID: 0033012226     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-199904000-00009     Document Type: Article

References (24)

1. Morrison JC. Preterm birth: A puzzle worth solving. Obstet Gynecol 1990;76:5S-12S.
2. McLean M, Walters WAW, Smith R. Prediction and early diagnosis of preterm labor: A critical review. Obstet Gynecol Survey 1993;-48:209-25.
3. Creasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol 1980;55:692-5.
4. Papiernik E, Bouyer J, Dreyfus J, Collin D, Winisdorffer G, Guegen S, et al. Prevention of preterm births: A perinatal study in Haguenau, France. Pediatrics 1985;76:154-8.
5. Herron MA, Katz M, Creasy RK. Evaluation of a preterm birth prevention program Preliminary report. Obstet Gynecol 1982;59:452-6.
6. Main DM, Richardson D, Gabbe SG, Strong S, Weller SC. Prospective evaluation of a risk scoring system for predicting preterm delivery in black inner city women. Obstet Gynecol 1987;69:61-6.
7. Holbrook RH, Laros RK, Creasy RK. Evaluation of a risk-scoring system for prediction of preterm labor. Am J Perinatol 1989;6:62-8.
8. Owen J, Goldenberg RL, Davis RO, Kirk KA, Copper RL. Evaluation of a risk scoring system as a predictor of preterm birth in an indigent population. Am J Obstet Gynecol 1990;163:873-9.
9. Mercer BM, Goldenberg RL, Das A, Moawad AH, Iams JD, Meis PJ, et al. The preterm prediction study. A clinical risk assessment system. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1996;174:1885-95.
10. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, et al Risk factors for prematurity and premature rupture of membranes: A prospective study of vaginal flora in pregnaney. Am J Obstet Gynecol 1984;150:965-72.
11. Graven MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and chlamydia trachomatis infection with adverse pregnancy outcome, JAMA 1986;256:1899-903.
12. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs, RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med 1995;333:1737-42.
13. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: Association in early and late pregnancy. Am J Obstet Gynecol 1993;169:175-8.
14. Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: Significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Am J Obstet Gynecol 1995;173:1231-5.
15. Lockwood CR, Wein R, Lapinski R, Casal D, Berkowitz G, Alvarez M, et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol 1993;169:798-804.
16. Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low-risk women. Br J Obstet Gynaecol 1995;102:207-12.
17. Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Logsdon V, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996;75:1054-6.
18. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 1996;87:643-8.
19. Feinberg RF, Kliman HJ, Bedian V, Monzon-Bordonaba F, Menzin AW, Wang CL. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site. Am J Obstet Gynecol 1995;172:1526-36.
20. Feinberg RF, Wang CL. Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: A caveat for cervicovaginal oncofetal fibronectin testing? Am J Obstet Gynecol 1994;171:1302-8.
21. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK. Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
22. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
23. Arkin CF, Wachtel MS. How many patients are necessary to assess test performance? JAMA 1990;263:275-8.
24. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-74.